TNFSF10 and melanoma: Similarly, as in case of the activity of selenoindirubin-N-glycosides 38 against lung cell carcinoma (Scheme 23), inhibition of melanoma cell proliferation and loss of cell viability were significantly increased by the presence of the death ligand TRAIL.